Common Contracts

Contract

Clinical Trial Agreement • May 25th, 2017

• Contract Type
  Clinical Trial Agreement
• Filed
  May 25th, 2017

CLINICAL TRIAL AGREEMENT The Clinical Trial Agreement (“Agreement”) is made by and between:  Krajská zdravotní a.s.,having a place of business at Sociální péče 3316/12A, 401 13 Ústí nad Labem, Czech Republic Identification number: 254 88 627, Tax identification number: CZ25488627, represented by Ing. Petr Fiala, managing director (the “Institution”), and  Quintiles Czech Republic, s.r.o.,having a place of business at Praha 5, Jinonice, Radlická 714/113a, zip code 158 00 Prague, Czech Republic, Identification number: 247 68 651, Tax identificationnumber: CZ247 68 651 (“Quintiles”), and  Merck KGaA,having a place of business at Frankfurter Strasse 250, 64393 Darmstadt, Germany, Identification number: HRB 6164 (“Sponsor”) Each a “Party” and together the “Parties”. Protocol Number: EMR10070-005 A Phase III, open-label, multicenter trial of avelumab1 (MSB0010718C) versusProtocol Title: platinum-based doubletas a first-line treatment of recurrent or Stage IV PD-L1+ non-small cell lung ca